Stipple Bio is a biotechnology company that offers cellular profiling and target discovery with epitope resolution.
Stipple Bio has raised $100.0M in total funding. The most recent round was Series A. The last funding was announced in April 2026.
Stipple Bio's investors include RA Capital Management, Google Ventures, OMX Ventures, Emerson Collective, Nextech Invest.
Stipple Bio is headquartered in Cambridge, United States.
Stipple Bio is a biotechnology company that offers cellular profiling and target discovery with epitope resolution.
Stipple Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Stipple Bio — Funding & Investors." VCBacked, April 6, 2026, https://www.vcbacked.co/company/stipple-bio. Accessed September 2, 2026.
VCBacked. (2026). Stipple Bio — Funding & Investors. Retrieved September 2, 2026, from https://www.vcbacked.co/company/stipple-bio
{{cite web |title=Stipple Bio — Funding & Investors |url=https://www.vcbacked.co/company/stipple-bio |website=VCBacked |access-date=September 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated